arrow
C

Catherine Voegele

world health organization
H指数:24
被引数:2,109

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Deep molecular profiling of lung neuroendocrine tumours and supra-carcinoids

肺神经内分泌肿瘤和类癌的深层分子谱分析

2026-08-270
OA
Assessment of the current and emerging criteria for the histopathological classification of lung neuroendocrine tumours in the lungNENomics project
2024-06-011
OAAI
Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity
2023-03-1627
OAAI
Genetic Analysis of Lung Cancer and the Germline Impact on Somatic Mutation Burden
2022-05-029
OAAI
Hepatitis B virus preS2Δ38-55 variants: A newly identified risk factor for hepatocellular carcinoma
2020-10-0121
OAAI
Circulating tumour-derived KRAS mutations in pancreatic cancer cases are predominantly carried by very short fragments of cell-free DNA
2020-05-0113
OAAI
Needlestack: an ultra-sensitive variant caller for multi-sample next generation sequencing data
2020-04-207
OAAI
Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study
2020-03-0156
OAAI
Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids
2019-08-20122
OAAI
Urinary TERT promoter mutations as non-invasive biomarkers for the comprehensive detection of urothelial cancer
2019-06-0148
OAAI
Multi-omics comparative analyses of pulmonary typical carcinoids, atypical carcinoids, and large-cell neuroendocrine carcinoma
2018-07-011
PRE
CASP9 germline mutation in a family with multiple brain tumors
2017-04-1712
OAAI
No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing
2016-02-2691
OAAI
Multigene testing of moderate-risk genes: be mindful of the missense
2016-01-1932
OAAI